NCT01967160View on ClinicalTrials.gov

Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid

CompletedOBSERVATIONAL
Enrollment

2,560

Participants

Timeline

Start Date

January 2, 2012

Primary Completion Date

August 5, 2019

Study Completion Date

August 5, 2019

Conditions
Osteonecrosis of the JawInfection Leading to Hospitalization
Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

lead

Amgen

INDUSTRY